Search Results 1741-1750 of 16417 for Maximum

1. A Study to Evaluate CB-839 HCl in Combination With Carfilzomib and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma - Mayo Clinic

   EXCEPTION: Patients may be on chronic steroids (maximum dose 10 mg/day prednisone equivalent) if they are being given for disorders other than myeloma; e.g., ...

2. First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid Tumors - Mayo Clinic

   This first-in-human study is conducted to identify the maximum tolerated dose (MTD) and dose-limiting toxicities (DLTs) of TP-0903 administered orally to ...

3. Stay safe if you exercise while taking opioids - Mayo Clinic News Network

   Changes in your heart rate and rhythm. Some people find that their heart beats more slowly or irregularly when they take opioid medications. · Breathing trouble.

4. Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival - Mayo Clinic

   Maximum diameter of individual metastasis in any dimension ≤ 5 cm. Metastases must be > 5 cm away from each other (defined as Edge to Edge of tumor):. If ...

5. Cancer Clinical Trials - Medical Professionals

   The purpose of this study is to determine the maximum tolerated dose (MTD) of AG-270 and characterize its dose-limiting toxicities (DLTs) when given daily ...

6. A Study to Evaluate INSTILADRIN® in Patients With High Grade, Bacillus Calmette-Guerin (BCG) Unresponsive NMIBC - Mayo Clinic

   No maximum limit to the amount of BCG administered; All visible papillary tumors must be resected and those with persistent T1 disease on transurethral ...

7. Mayo Clinic Q and A: Is intermittent fasting good for weight loss?

   Is intermittent fasting a healthy way to lose weight? Is this just skipping a meal occasionally or is there more to it?

8. Individuals with controlled hypertension can safely donate a kidney - Mayo Clinic

   Well-controlled hypertension on a maximum of two medications; Absence of any target organ damage such as heart disease or proteinuria; Normal kidney function ...

9. Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL - Mayo Clinic

   TP-0903 is currently being evaluated in patients with refractory solid tumors (TP-0903-101). This proposed study is designed to identify the maximum tolerated ...

10. Thyroid Cancer Clinical Trials - Mayo Clinic Research

    ... maximum tolerated dose (MTD) and/or recommended Phase 2 dose (RP2D) of E7386. Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid ...